Aeras is a nonprofit biotechnology organization developing new, effective tuberculosis (TB) vaccines that are affordable and accessible to all who need them. We work through partnerships in both the public and private sectors, with individuals, research organizations, academic institutions, funders, policymakers and others around the world to advance TB vaccine science and development.

Over the past decade, Aeras has made significant contributions to the marked progress of the TB vaccine field. Together with our partners and collaborators, we are advancing the best TB vaccine science and working toward a common goal of ending the threat of TB. Aeras’s headquarters are located in Rockville, Maryland, with offices in Cape Town, South Africa and Beijing, China.